NCT05824988View on ClinicalTrials.gov

Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 14, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Mycobacterium Avium ComplexMycobacterium Avium-Intracellulare InfectionGram-Positive Bacterial InfectionsMycobacterium Infections
Interventions
OTHER

Drug exposure

Drug concentrations will be measured after one-month antimycobacterial treatment. Area under drug concentration-time curve (AUC) and maximum concentration (Cmax) will be calculated.

Trial Locations (1)

200433

RECRUITING

Shanghai Pulmonary Hospital, Shanghai

All Listed Sponsors
collaborator

Fudan University

OTHER

collaborator

University of Sydney

OTHER

collaborator

Karolinska Institutet

OTHER

collaborator

Shanghai Municipal Center for Disease Control and Prevention

OTHER

lead

Shanghai Pulmonary Hospital, Shanghai, China

OTHER